Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M2M Imaging is a specialized provider of preclinical imaging solutions for the life sciences and biomedical research sectors in Australia and New Zealand. The company focuses on the distribution, installation, and maintenance of advanced imaging modalities, including compact MRI, PET, SPECT, and CT systems tailored for small animal research. M2M Imaging represents leading global brands such as Aspect Imaging and Mediso, providing researchers with high-resolution tools for drug discovery and disease characterization. In addition to hardware, the company offers expert technical support and application training to ensure optimal research outcomes. Their services facilitate non-invasive longitudinal studies across various therapeutic areas, including oncology and neuroscience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M2M Imaging Australia.